Skip to main content
Clinical Trials/NCT03863977
NCT03863977CompletedPhase 2

Comparison of Post-operative Analgesic Effects of Two Doses of Dexamethasone Added to Bupivacaine in Ultrasound-guided Transversusabdominis Plane (TAP) Block for Inguinal Hernia Repair

Assiut University1 site in 1 country90 target enrollmentStarted: March 15, 2019Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 2
Status
Completed
Enrollment
90
Locations
1
Primary Endpoint
time of the first analgesic request

Study Overview

Brief Summary

To compare the postoperative analgesic effect of two doses of dexamethasone added to bupivacaine in ultrasound-guided TAP block for inguinal hernia repair.

Detailed Description

The transverses abdominis plane block (TAP block) is a regional anesthesia technique that provides analgesia following abdominal surgery . The TAP block significantly reduces pain after open inguinal hernia repair, regardless of whether it is used as a primary anesthesia technique or as a complement to general anesthesia, spinal or local anesthesia .

The investigators designed this study to compare the postoperative analgesic effect of two doses of dexamethasone( 4 mg and 8 mg ) added to bupivacaine in ultrasound-guided TAP block for inguinal hernia repair.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Masking Description

A blinded physician prepared the study medications in color coded syringes.

Eligibility Criteria

Ages
18 Years to 60 Years (Adult)
Sex
Male
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients' age from 18 to 60 years old,
  • physical status ASA I-II (by the American Society of Anesthesiologists),
  • Elective unilateral open inguinal hernia repair,
  • Under spinal anesthesia

Exclusion Criteria

  • age < 18 or > 60,
  • American society of anesthesiologist (ASA)class III-IV,
  • known allergy to amino amide local anesthetics,
  • skin infection and diseases at site of injection.
  • coagulation disorders,
  • patients with body mass index (BMI) > 35 kg/m2,
  • scrotal hernias,

Arms & Interventions

Dex4 group

Active Comparator

After the surgery, the patients in this group will receive 4 mg dexamethasone added to 1mg/kg of 0.5% bupivacaine in the TAP block.

Intervention: Dexamethasone (Drug)

Dex4 group

Active Comparator

After the surgery, the patients in this group will receive 4 mg dexamethasone added to 1mg/kg of 0.5% bupivacaine in the TAP block.

Intervention: Bupivacaine (Drug)

Dex8 group

Active Comparator

After the surgery, the patients in this group will receive 8 mg dexamethasone added to 1mg/kg of 0.5% bupivacaine in the TAP block.

Intervention: Dexamethasone (Drug)

Dex8 group

Active Comparator

After the surgery, the patients in this group will receive 8 mg dexamethasone added to 1mg/kg of 0.5% bupivacaine in the TAP block.

Intervention: Bupivacaine (Drug)

control group

Active Comparator

After the surgery, the patients in this group will 1mg/kg of 0.5% bupivacaine in the TAP block.

Intervention: Bupivacaine (Drug)

Outcomes

Primary Outcomes

time of the first analgesic request

Time Frame: in the first postoperative 24 hours

time of the first analgesic request in the first postoperative 24 hours ,patients will receive analgesia if visual analog scale (VAS) score more than 3

Secondary Outcomes

  • change in visual analog scale (VAS)(2nd, 4th, 8th, 16th, and 24th postoperative hours.)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Amani Hassan Abdel-Wahab

Principal Investigator

Assiut University

Study Sites (1)

Loading locations...

Similar Trials